Dr Glenn Begley

Dr Glenn Begley


Immediate Past Chief Executive Officer
BioCurate Pty, Ltd
Elected in 2015
Citation on election

Dr Begley’s research contributions include discovery of key factors controlling normal and malignant cells. His demonstration that stem cells, normally resident in bone marrow, can be enriched in blood and hasten patient recovery has revolutionized transplantation approaches. At Amgen over 25 of his research programs entered clinical trials. His work has impacted the lives of millions of cancer patients and has been recognized by election as Fellow, Royal Colleges of Pathologists UK (1997) and Australasia (2002); American Society of Clinical Investigation (2002); Association of American Physicians (2008); and inaugural inductee into the Royal Melbourne Hospital’s Research “Hall of Fame” (2014).

Keep up to date with the latest news

By providing your email address, you consent to it being added to our mailing list.